Xiaoxia W. Chen
No. 507, Zheng Min Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 31, 2025
Enzyme-linked lectin assay for amplified electrochemical detection of HPV DNA.
Journal: Biosensors & bioelectronics
Published: September 16, 2025
Exploration of patient plasma exosomes as biomarkers for predicting lung cancer brain metastasis.
Journal: Frontiers in medicine
Published: August 18, 2025
Pulmonary arterial blowout syndrome as a serious adverse event in patients with advanced lung cancer: a 12-year retrospective study.
Journal: European radiology
Published: June 02, 2025
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial.
Journal: Signal transduction and targeted therapy
Published: April 03, 2025
BIRC5 expression correlates with immunosuppressive phenotype and predicts inferior response to immunotherapy in lung adenocarcinoma.
Journal: Journal of thoracic disease
Published: February 03, 2025
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: September 24, 2024
AYVM to AYMM Transition on HER2 Exon 20 Insertion Induces Tyrosine Kinase Inhibitor Resistance in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 31, 2024
Single-cell RNA sequencing reveals microenvironmental infiltration in non-small cell lung cancer with different responses to immunotherapy.
Journal: The journal of gene medicine
Published: July 09, 2024
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer.
Journal: Signal transduction and targeted therapy
Published: May 18, 2024
Differential expression of the MYC-Notch axis drives divergent responses to the front-line therapy in central and peripheral extensive-stage small-cell lung cancer.
Journal: MedComm
Published: April 19, 2024
Last Updated: 09/26/2026